4//SEC Filing
Kunkel Lori Anne 4
Accession 0001415889-24-010678
CIK 0001672619other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 8:39 PM ET
Size
5.5 KB
Accession
0001415889-24-010678
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Award
Stock Option (right to buy)
2024-04-08+37,882→ 37,882 totalExercise: $18.30Exp: 2034-04-08→ Common Stock (37,882 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option will vest on May 8, 2024 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001536368
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 8:39 PM ET
- Size
- 5.5 KB